These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 28674306)

  • 1. A Comparison of the Phosphorus Content in Prescription Medications for Hemodialysis Patients in Japan.
    Shimoishi K; Anraku M; Uto A; Iohara D; Hirayama F; Kadowaki D; Zingami S; Maruyama T; Otagiri M
    Yakugaku Zasshi; 2017; 137(7):903-908. PubMed ID: 28674306
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A dearth of data: the problem of phosphorus in prescription medications.
    Sherman RA; Ravella S; Kapoian T
    Kidney Int; 2015 Jun; 87(6):1097-9. PubMed ID: 25760324
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Phosphate Content of Prescription Medication: A New Consideration.
    Sherman RA; Ravella S; Kapoian T
    Ther Innov Regul Sci; 2015 Nov; 49(6):886-889. PubMed ID: 30222371
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phosphate-Containing Prescription Medications Contribute to the Daily Phosphate Intake in a Third of Hemodialysis Patients.
    Nelson SM; Sarabia SR; Christilaw E; Ward EC; Lynch SK; Adams MA; Holden RM
    J Ren Nutr; 2017 Mar; 27(2):91-96. PubMed ID: 27814946
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phosphorus Content of Commonly Prescribed Medications Among Patients With Chronic Kidney Disease.
    Lim R; How P; Lee C; Yong XN; Wong WK; Lo E
    J Ren Nutr; 2022 Jan; 32(1):22-29. PubMed ID: 34625333
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical efficacy, safety and anti-inflammatory activity of two sevelamer tablet forms in patients on low-flux hemodialysis.
    Tzanno-Martins C; Biavo BM; Ferreira-Filho O; Ribeiro-Junior E; João-Luiz MV; Degaspari S; Scavone C; Kawamoto E
    Int J Immunopathol Pharmacol; 2014; 27(1):25-35. PubMed ID: 24674676
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hidden phosphorus in popular beverages.
    Murphy-Gutekunst L
    Nephrol Nurs J; 2005; 32(4):443-5. PubMed ID: 16180787
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phosphates in medications: Impact on dialysis patients
.
    Sawin DA; Ma L; Stennett A; Ofsthun N; Himmele R; Kossmann RJ; Maddux FW
    Clin Nephrol; 2020 Apr; 93(4):163-171. PubMed ID: 32049627
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of convective flow on phosphorus removal in maintenance hemodialysis patients.
    Lornoy W; De Meester J; Becaus I; Billiouw JM; Van Malderen PA; Van Pottelberge M
    J Ren Nutr; 2006 Jan; 16(1):47-53. PubMed ID: 16414441
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Extra-phosphate load from food additives in commonly eaten foods: a real and insidious danger for renal patients.
    Benini O; D'Alessandro C; Gianfaldoni D; Cupisti A
    J Ren Nutr; 2011 Jul; 21(4):303-8. PubMed ID: 21055967
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Absorbable phosphate in medication.
    Santoro D; Savica V; Trifirò G
    Kidney Int; 2016 Mar; 89(3):721. PubMed ID: 26880465
    [No Abstract]   [Full Text] [Related]  

  • 12. [Information about phosphorus additives and nutritional counseling].
    Kido S; Nomura K; Sasaki S; Shiozaki Y; Segawa H; Tatsumi S
    Clin Calcium; 2012 Oct; 22(10):1583-91. PubMed ID: 23023640
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The renal diet in 2010: is it time for a shake up?
    Kolbe N
    Nephrol News Issues; 2010 Jul; 24(8):21-3. PubMed ID: 20695318
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dietary phosphorus restriction in dialysis patients: potential impact of processed meat, poultry, and fish products as protein sources.
    Sherman RA; Mehta O
    Am J Kidney Dis; 2009 Jul; 54(1):18-23. PubMed ID: 19376617
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Survey of Drug Burden in Patients Undergoing Maintenance Hemodialysis in Japan.
    Iwashita Y; Ohya M; Kunimoto S; Iwashita Y; Mima T; Negi S; Shigematsu T
    Intern Med; 2018 Oct; 57(20):2937-2944. PubMed ID: 29780106
    [TBL] [Abstract][Full Text] [Related]  

  • 16. When is a "generic" medication not really a generic?
    Howland RH
    J Psychosoc Nurs Ment Health Serv; 2010 Feb; 48(2):13-6. PubMed ID: 20166651
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The extra-phosphate intestinal load from medications: is it a real concern?
    Cupisti A; Moriconi D; D'Alessandro C; Verde F; Marchini M; Saba A; Egidi MF
    J Nephrol; 2016 Dec; 29(6):857-862. PubMed ID: 27084800
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Salivary phosphorus and phosphate content of beverages: implications for the treatment of uremic hyperphosphatemia.
    Savica V; Calò LA; Monardo P; Santoro D; Mallamace A; Muraca U; Bellinghieri G
    J Ren Nutr; 2009 Jan; 19(1):69-72. PubMed ID: 19121775
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nondialysis (home) medication utilization and cost in diabetic and nondiabetic hemodialysis patients.
    Manley HJ; Cannella CA
    Nephrol News Issues; 2005 Jan; 19(2):27-8, 33-4, 36-8. PubMed ID: 15717572
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management of hyperphosphataemia: practices and perspectives amongst the renal care community.
    Nagel CJ; Casal MC; Lindley E; Rogers S; Pancířová J; Kernc J; Copley JB; Fouque D
    J Ren Care; 2014 Dec; 40(4):230-8. PubMed ID: 24814866
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.